JONJEE(600872)

Search documents
中炬高新:2024年报净利润8.93亿 同比下降47.38%
Tong Hua Shun Cai Bao· 2025-04-08 13:58
二、前10名无限售条件股东持股情况 一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益(元) | 1.1438 | 2.2010 | -48.03 | -0.7682 | | 每股净资产(元) | 0 | 5.99 | -100 | 3.83 | | 每股公积金(元) | 0.54 | 0 | 0 | 0 | | 每股未分配利润(元) | 5.93 | 5.36 | 10.63 | 3.44 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 55.19 | 51.39 | 7.39 | 53.41 | | 净利润(亿元) | 8.93 | 16.97 | -47.38 | -5.92 | | 净资产收益率(%) | 18.24 | 44.00 | -58.55 | -17.41 | 数据四舍五入,查看更多财务数据>> 三、分红送配方案情况 10派4.2元(含税) 前十大流通股东累计持有: 30796.89万 ...
中炬高新(600872) - 中炬高新关于公司副总经理辞职的公告
2025-04-02 12:49
证券代码:600872 证券简称:中炬高新 公告编号:2025-011 中炬高新技术实业(集团)股份有限公司 关于公司副总经理辞职的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 中炬高新技术实业(集团)股份有限公司(以下简称:公司)董 事会于近日收到公司副总经理吴剑先生的辞职报告。吴剑先生因个人 原因申请辞去公司副总经理职务。根据《公司法》《公司章程》等有 关规定,吴剑先生的辞职报告自送达公司董事会之日起生效。辞职后, 吴剑先生将不在公司及下属子公司担任任何职务,其辞职不会对公司 的正常运作及经营管理产生影响。 截至本公告日,吴剑先生持有公司股份 365,443 股(因公司股权 激励已获授但尚未解除限售的限制性股票 365,443 股),吴剑先生辞 职后其所持公司股份将依据相关法律、法规、规范性文件及公司《2024 年限制性股票激励计划》的相关规定进行管理。 特此公告。 中炬高新技术实业(集团)股份有限公司董事会 2025 年 4 月 2 日 1 ...
中炬高新(600872) - 中炬高新关于董事会、监事会延期换届的提示性公告
2025-03-21 10:15
中炬高新技术实业(集团)股份有限公司(以下简称:公司)第 十届董事会、监事会任期将于 2025 年 3 月 22 日届满,鉴于公司新一 届董事会、监事会候选人的提名工作尚未完成,为保证公司董事会、 监事会相关工作的连续性和稳定性,公司董事会、监事会的换届选举 将适当延期,公司董事会各专门委员会委员及高级管理人员的任期亦 相应顺延。 公司正在积极筹备换届选举相关工作,将于本公告发布后不超过 2 个月内完成换届选举工作。在换届选举工作完成前,公司第十届董 事会和监事会全体成员、董事会各专门委员会委员及现任高级管理人 员将依照相关法律、法规和《公司章程》等有关规定继续履行相应的 义务和职责。公司董事会、监事会延期换届不会影响公司的正常运营。 公司将积极推进董事会、监事会换届选举工作进程,并及时履行信息 披露义务。 证券代码:600872 证券简称:中炬高新 公告编号:2025-010 中炬高新技术实业(集团)股份有限公司 关于董事会、监事会延期换届的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 特此公告。 中炬高 ...
中炬高新(600872) - 中炬高新第十届董事会第二十七次会议决议公告
2025-03-18 11:15
证券代码:600872 证券简称:中炬高新 公告编号:2025-009 表决结果:8 票赞成,0 票反对,0 票弃权。 1、战略委员会:余健华(召集人)、林颖、方祥、甘耀仁、李 刚、万鹤群、刘戈锐; 2、审计委员会:甘耀仁(召集人)、方祥、李刚、余健华、万 鹤群; 3、提名委员会:方祥、甘耀仁、李刚、余健华、梁大衡;经委 员会选举,方祥当选提名委员会召集人; 中炬高新技术实业(集团)股份有限公司 第十届董事会第二十七次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 中炬高新技术实业(集团)股份有限公司(以下简称:中炬高新、 公司)第十届董事会第二十七次会议于 2025 年 3 月 13 日发出会议通 知,于 2025 年 3 月 18 日上午以现场与通讯相结合的方式召开。会议 应到董事 8 人,实到 8 人,本次会议有效表决票数为 8 票。部分高管 列席了会议,本次会议的召集、召开及表决程序符合法律法规及《公 司章程》的有关规定。会议由董事长余健华先生主持,经到会董事认 真审议,以书面表决方式,审议通过了以 ...
中炬高新(600872) - 中炬高新简式权益变动报告书(中山润田)
2025-02-25 10:17
中炬高新技术实业(集团)股份有限公司 简式权益变动报告书 股份变动性质:减少 签署日期:2025年2月 信息披露义务人声明 一、信息披露义务人依据《中华人民共和国公司法》、《中华人民共和国证 券法》、《上市公司收购管理办法》、《公开发行证券公司信息披露内容与格式 准则第 15 号——权益变动报告书》及相关的法律、法规编写本报告书。 二、依据上述法律法规的规定,本报告书已全面披露了信息披露义务人所持 有的中炬高新技术实业(集团)股份有限公司股份变动情况。 截至本报告书签署之日,除本报告书披露的持股信息外,信息披露义务人没 有通过任何其他方式增加或减少在中炬高新技术实业(集团)股份有限公司拥有 权益的股份。 三、信息披露义务人签署本报告书已获得必要的授权和批准,其履行亦不违 反信息披露义务人章程或内部规则中的任何条款,或与之相冲突。 四、本次信息披露的原因是中山润田投资有限公司基于债权人执行法院裁定 书,导致股权比例低于 5%。 上市公司名称:中炬高新技术实业(集团)股份有限公司 股票上市地点:上海证券交易所 股票简称:中炬高新 股票代码:600872 信息披露义务人:中山润田投资有限公司 住所:中山市火炬开发区 ...
中炬高新-AI-纪要
2025-02-21 02:39
Summary of Conference Call for Zhongju Gaoxin Company Overview - The conference call pertains to Zhongju Gaoxin, a company involved in the food and beverage industry, particularly focusing on sauces and condiments. Key Points and Arguments Sales and Inventory Management - In January, there was a decline in shipments, but inventory levels remained normal, with good digestion of stock. An increase in channel replenishment and sales velocity is expected in February and March, with specific data to be shared later [2][4][5] - The company plans to increase sales expenses, particularly in the restaurant sector, while maintaining stable costs. A gradual improvement in gross margin is anticipated [2][7] Distributor and Channel Development - The number of distributors significantly increased in 2024, exceeding the target of 300, primarily in non-core urban areas. The company aims to continue expanding into untapped areas and enhance resource development in the restaurant sector [2][8] - The restaurant sector is identified as a key channel for 2025, with adjustments made in product offerings, personnel, and organizational structure to support this strategy [2][10][11] Product Development and Market Strategy - Despite attempts to upgrade product health features, sales were disappointing. The company plans to develop functional products tailored to different scenarios or consumer groups, focusing on the restaurant market [2][9][17] - The company aims to enhance product quality through improvements in raw materials and enzyme technology, while also focusing on health-oriented product development [17] Pricing and Profitability - Following a price increase in September, product prices stabilized, and sales did not decline further, improving distributor profit margins. The company provided support to distributors for pre-holiday stocking and implemented rebate policies [3][13][14] - The company plans to increase the dividend payout ratio and may initiate stock buybacks based on market fluctuations [3][20] Marketing and Organizational Changes - Significant personnel changes occurred during the marketing system reform, leading to a slower adaptation process. The company plans to slow down the reform pace in the second half of the year to provide more support to employees [11][12] - The company is focusing on developing new channels, particularly in the C-end market, and is negotiating with large supply chain retailers to stabilize its market position [21] Future Outlook and Strategic Goals - The management expressed confidence in achieving revenue and profit targets for the next three years, despite anticipated intensified competition in the industry. Plans include enhancing channels, products, and management to adapt to market conditions [18] - The company has established an overseas division to manage international business, targeting regions such as Southeast Asia and Europe, with expectations for project launches in 2025 [19] Shareholder Returns and Corporate Governance - The company aims to enhance shareholder returns through increased dividends and potential stock buybacks, pending board approval [20] - The controlling shareholder's stake remains stable, with no immediate plans for further share acquisition or significant market impact anticipated from recent changes in shareholding [19] Additional Important Information - The company is actively engaging in discussions regarding land acquisition but has no new updates to report [16] - The focus for 2025 will be on product innovation while also recognizing the importance of channel growth, particularly in the restaurant sector [16][22]
中炬高新(600872) - 中炬高新关于持股5%以上股东所持公司部分股份被司法拍卖完成过户登记暨权益变动后持股比例低于5%的提示性公告
2025-02-18 12:32
证券代码:600872 证券简称:中炬高新 公告编号:2025-008 中炬高新技术实业(集团)股份有限公司 关于持股 5%以上股东所持公司部分股份被司法拍卖 完成过户登记暨权益变动后持股比例低于 5%的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: 本次被司法拍卖完成过户登记股份为中炬高新持股 5%以上股 东中山润田所持公司 9,000,000 股股份,占公司总股本的 1.15%。受 让方在受让前述司法拍卖股份后 6 个月内不得减持。 本次权益变动后,中山润田持有公司股份总数为 35,110,000 股, 持股比例下降至 4.48%。中山润田不再属于公司持股 5%以上的股东。 本次权益变动不触及要约收购,不会对公司经营活动产生影响。 一、司法拍卖的基本情况 中炬高新技术实业(集团)股份有限公司(以下简称:中炬高新、 公司)于 2024 年 12 月 18 日披露《中炬高新关于持股 5%以上股东所 持部分公司股份将被司法拍卖的提示性公告》(公告编号:2024-069), 深圳市福田区人民法院于 ...
中炬高新:2024年内部持续推进改革,少数股权收回增厚来年报表业绩
中银证券· 2025-02-07 07:26
Investment Rating - The report maintains an "Accumulate" rating for the company, with a market price of RMB 21.13 and an industry rating of "Outperform" compared to the market [1][3]. Core Insights - The company, Zhongju Gaoxin, is expected to achieve a net profit attributable to shareholders of approximately RMB 679 million to RMB 1.018 billion in 2024, representing a decrease of about 40%-60%. However, the non-recurring net profit is projected to increase by 20%-40% year-on-year, reaching RMB 629 million to RMB 734 million [3][7]. - The company is actively pursuing internal reforms and recovering minority interests, which are expected to enhance the financial performance in the coming years [3][7]. Summary by Sections Financial Performance - The company’s main revenue for 2022 was RMB 5.341 billion, with a projected decline to RMB 5.139 billion in 2023, followed by an expected increase to RMB 5.502 billion in 2024 and further growth to RMB 6.279 billion in 2025 [6][8]. - The EBITDA is forecasted to rise from RMB 749 million in 2023 to RMB 1.046 billion in 2024, and to RMB 1.295 billion in 2025 [6][8]. - The net profit attributable to shareholders is expected to recover from a loss of RMB 592 million in 2022 to a profit of RMB 1.697 billion in 2023, followed by RMB 710 million in 2024 and RMB 903 million in 2025 [6][8]. Market Dynamics - The company is experiencing fluctuations in quarterly performance due to price adjustments and a challenging external consumption environment. The first quarter of 2024 is expected to show a revenue growth of 10.2%, while the second quarter may see a decline of 12.1% [7]. - The company is implementing cost reduction and efficiency improvement measures, benefiting from lower raw material prices, which are expected to positively impact the non-recurring net profit in 2024 [7]. Strategic Initiatives - The company is recovering minority interests, which is anticipated to significantly contribute to the profit in 2025. The acquisition of a 20% stake in Chubang Company is expected to add approximately 6.31% to the net profit [7]. - The company has outlined a strategic plan to achieve RMB 10 billion in revenue for its main product line, Meiwai Xian, by 2026, although achieving this target may be challenging due to team integration and external conditions [7].
中炬高新(600872) - 中炬高新关于持股5%以上股东所持公司部分股份被司法拍卖完成过户登记的公告
2025-02-06 11:19
根据淘宝网司法拍卖网络平台于 2024 年 12 月 31 日公示的《成 交确认书》显示,前述股份被李涛竞得。具体内容详见公司于 2025 年 1 月 1 日披露的《中炬高新关于持股 5%以上股东所持部分公司股 份被司法拍卖的进展公告》(公告编号:2024-070)。 1 中炬高新技术实业(集团)股份有限公司 关于持股 5%以上股东所持公司部分股份 被司法拍卖完成过户登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: 本次被司法拍卖完成过户登记股份为中炬高新持股 5%以上股 东中山润田所持公司 2,435,843 股股票,占公司总股本的 0.31%。本 次过户登记完成后,中山润田对公司持股比例从 5.94%变为 5.63%。 一、司法拍卖的基本情况 中炬高新技术实业(集团)股份有限公司(以下简称:公司、中 炬高新)于 2024 年 12 月 3 日披露《中炬高新关于持股 5%以上股东 所持部分公司股份将被司法拍卖的提示性公告》(公告编号: 2024-067),广东省中山市中级人民法院于 2024 ...
中炬高新:24年收官,扣非归母净利润提升明显
Tianfeng Securities· 2025-02-03 12:47
Investment Rating - The report maintains a "Buy" rating for the company, with a target price not specified [4]. Core Views - The company is expected to achieve a net profit attributable to shareholders of approximately 679 million to 1.018 billion yuan in 2024, representing a year-on-year decrease of about 40% to 60% [1]. - The non-recurring net profit is projected to be around 629 million to 734 million yuan, indicating a year-on-year growth of approximately 20% to 40% [1]. - The company has successfully acquired a 20% minority stake in Chubang Company, which is anticipated to enhance net profit [2]. - The company is actively pursuing reforms, including the establishment of a dedicated channel expansion department and a new retail division to enhance e-commerce efforts [2]. - Revenue is expected to grow steadily in 2024, with projected revenues of 5.829 billion, 6.321 billion, and 7.028 billion yuan for 2024, 2025, and 2026 respectively, reflecting growth rates of 12%, 10%, and 10% [2]. Financial Summary - The company reported a revenue of 5.139 billion yuan in 2023, with an expected revenue of 5.759 billion yuan in 2024, marking a growth rate of 12.07% [4]. - The net profit attributable to shareholders for 2023 was 1.697 billion yuan, with an expected profit of 859.88 million yuan in 2024, indicating a decrease of 49.33% [4]. - The earnings per share (EPS) is projected to be 1.10 yuan in 2024, compared to 2.17 yuan in 2023 [4]. - The company’s price-to-earnings (P/E) ratio is expected to be 19.24 in 2024, decreasing to 15.17 by 2026 [4].